Protease inhibitors: role and potential therapeutic use in human cancer.
about
SEL1L affects human pancreatic cancer cell cycle and invasiveness through modulation of PTEN and genes related to cell-matrix interactionsCross-domain inhibition of TACE ectodomainAnti-invasive and antiangiogenic effects of MMI-166 on malignant glioma cellsBreast cancer and metabolic syndrome linked through the plasminogen activator inhibitor-1 cycleAmplification of chromosome 21q22.3 harboring trefoil factor family genes in liver fluke related cholangiocarcinoma is associated with poor prognosisRequirement for matrix metalloproteinase-9 (gelatinase B) expression in metastasis by murine prostate carcinomaA systems biology approach to defining metastatic biomarkers and signaling pathwaysImbalance between serum matrix metalloproteinase-2 and its inhibitor as a predictor of recurrence of urothelial cancer.'Proteolytic switching': opposite patterns of regulation of gelatinase B and its inhibitor TIMP-1 during human melanoma progression and consequences of gelatinase B overexpressionFrequent loss of cystatin E/M expression implicated in the progression of prostate cancer.Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice.Nutrient and nonnutrient components of legumes, and its chemopreventive activity: a review.HIV-protease inhibitors for the treatment of cancer: Repositioning HIV protease inhibitors while developing more potent NO-hybridized derivatives?Redox regulation of matrix metalloproteinase gene family in small cell lung cancer cells.The chemopreventive properties of soy isoflavonoids in animal models of breast cancer.Collagenase: a key enzyme in collagen turnover.Proteinase inhibitors reduce basement membrane degradation by human breast cancer cell lines.Evaluation of MMP-9 and MMP-2 and their suppressor TIMP-1 and TIMP-2 in adenocarcinoma of esophagogastric junction.Peptidyl vinyl sulphones: a new class of potent and selective cysteine protease inhibitors: S2P2 specificity of human cathepsin O2 in comparison with cathepsins S and L.High levels of TIMP-2 correlate with adverse prognosis in breast cancer.
P2860
Q24550889-9E3FC12B-3AC4-4427-86E7-9CDAB799F133Q30499696-A078149E-F198-4075-81DC-97DEBAC3613BQ33619924-C5365101-D888-448E-80EB-300AB90025E0Q33715393-C9F13BC3-5D5B-4E0F-9319-05616EE37989Q33865984-5291A8CF-E68C-4B46-806A-94ABA174F629Q35763791-CD95436A-341C-405B-9822-55C349362A7FQ36199602-B93EDDF9-A212-4FFF-985E-A0D1359CC52DQ36291671-43AFB66A-B1D7-4406-A6A3-BC01D4C45394Q36617875-86D1EA67-91D5-4651-B4D8-681F93D59421Q37294189-B9C5BFDB-AA20-42BE-8A78-9371F4FC0ECFQ37452281-DD9A1A6C-F455-4B16-9279-46976FBB2FD9Q38364734-5736CBA0-F89E-4B51-955E-9AF8E9CB19E6Q39015233-F39C2DB7-E9DE-428C-A9AD-55EDDE66AD6CQ40395610-3EAC56A1-2CFA-406A-A4A2-F6F90613834DQ40865638-623D62DB-5034-4D5B-B01B-F6CF9A55A0C1Q41481774-08268067-18BA-4F32-97BB-6B6150C381F8Q41909966-AF53485C-5141-4602-80D6-AB7A97FB4DEEQ42407540-92C34C04-7999-42A3-AF4D-40F574DAEE48Q42981725-7C0CDB1D-4A6E-43A7-B0B7-1DD7E97F12FCQ52141709-E7236915-D524-4412-AEA7-52F6FB64E99B
P2860
Protease inhibitors: role and potential therapeutic use in human cancer.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Protease inhibitors: role and potential therapeutic use in human cancer.
@en
type
label
Protease inhibitors: role and potential therapeutic use in human cancer.
@en
prefLabel
Protease inhibitors: role and potential therapeutic use in human cancer.
@en
P1476
Protease inhibitors: role and potential therapeutic use in human cancer.
@en
P2093
P304
P356
10.1016/0959-8049(94)00460-M
P577
1994-01-01T00:00:00Z